Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph early_phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Other(3)

Detailed Status

unknown3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

completed125%
unknown375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

NCT05884463
unknownnot_applicable

18F-FAPI PET/CT in Patients With Various Types of Cancer

NCT05810324
unknownearly_phase_1

Tracer Targeting FAP PET Imaging in Patients

NCT05691894
unknown

18F-FAPI PET in the Diagnosis of Liver Fibrosis

NCT05262647

Clinical Trials (4)

Showing 4 of 4 trials
NCT05884463Not Applicable

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

Completed
NCT05810324Not Applicable

18F-FAPI PET/CT in Patients With Various Types of Cancer

Unknown
NCT05691894Early Phase 1

Tracer Targeting FAP PET Imaging in Patients

Unknown
NCT05262647

18F-FAPI PET in the Diagnosis of Liver Fibrosis

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4